Compile Data Set for Download or QSAR
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 8080
TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232965(US9353115, 1)
Affinity DataIC50: 72nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232966(US9353115, 54)
Affinity DataIC50: 142nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232969(US9353115, 57)
Affinity DataIC50: 271nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232975(US9353115, 63)
Affinity DataIC50: 497nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232972(US9353115, 60)
Affinity DataIC50: 604nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232973(US9353115, 61)
Affinity DataIC50: 2.74E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232974(US9353115, 62)
Affinity DataIC50: 3.29E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232967(US9353115, 55)
Affinity DataIC50: 5.20E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232971(US9353115, 59)
Affinity DataIC50: 7.53E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232968(US9353115, 56)
Affinity DataIC50: 8.01E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM232970(US9353115, 58)
Affinity DataIC50: 1.12E+4nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
Go to US Patent